Status:

COMPLETED

Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

Lead Sponsor:

Astellas Pharma Inc

Collaborating Sponsors:

UCB Japan Co. Ltd.

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

20-74 years

Phase:

PHASE3

Brief Summary

The objectives of this study are to evaluate the safety and efficacy of certolizumab pegol as add-on medication to methotrexate over the long term in Japanese RA patients transferred from Study 275-08...

Detailed Description

This study was initiated by Otsuka Pharmaceutical Co., Ltd and transferred to Astellas on 12/04/2012.

Eligibility Criteria

Inclusion

  • Subjects who participated in Study 275-08-001 and meet all of the criteria described below.
  • Patients who did not reach ACR20, and prematurely discontinued Study 275-08-001 at Week 16 or completed Study 275-08-001 by Week 24.
  • Patients who are able to receive treatment with MTX, by Week 52.

Exclusion

  • Patients who experienced an important protocol deviation as mentioned below during Study 275-08-001.
  • Patients who received live or attenuated vaccines during Study 275-08-001(Except for influenza or pneumococcal vaccines).
  • Patients who were found to have tuberculosis on a chest X-ray during Study 275-08-001.
  • Patients who required treatment for the same infection at two or more different times during Study 275-08-001
  • Women who are pregnant, are lactating, of childbearing potential and wish to conceive during the study and post-study 3 months.
  • Patients whom the investigator has decided to be inappropriate for participation in the study

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

285 Patients enrolled

Trial Details

Trial ID

NCT00851318

Start Date

March 1 2009

End Date

June 1 2013

Last Update

November 3 2014

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Chubu Region, Japan

2

Chugoku Region, Japan

3

Hokkaido Region, Japan

4

Kanto Region, Japan